Poland: 'Original' vs 'Substitute' Drug Labeling Skews Prescribing

A Polish media report highlights how the terms 'original' and 'substitute' for off-patent drugs bias doctor and patient choices, despite identical therapeutic effects. The framing may distort market competition and healthcare costs. The piece is opinion-driven, lacking specific data or policy proposals.